Arzneimittelforschung 2011; 61(3): 186-190
DOI: 10.1055/s-0031-1296187
Analgesics · Anti-inflammatories · Antiphlogistics · Antirheumatic Drugs
Editio Cantor Verlag Aulendorf (Germany)

Synthesis and screening of cyclooxygenase inhibitory activity of some 1,3-dioxoisoindoline derivatives

Authors

  • Murat Çizmecioğlu

    1   Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ege University Bornova, Izmir, Turkey
  • Varol Pabuççuoğlu

    1   Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ege University Bornova, Izmir, Turkey
  • Petek Ballar

    2   Department of Biochemistry, Faculty of Pharmacy, Ege University Bornova, Izmir, Turkey
  • Aysun Pabuççuoğlu

    2   Department of Biochemistry, Faculty of Pharmacy, Ege University Bornova, Izmir, Turkey
  • Zeynep Soyer

    1   Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ege University Bornova, Izmir, Turkey
Further Information

Publication History

Publication Date:
28 November 2011 (online)

Preview

Abstract

In this study, 15 compounds bearing N,N-phthaloylacetamide structure designed by the molecular simplification approach based on thalidomide structure were synthesized and evaluated for inhibitory potencies against cyclooxgenase (COX) isoenzymes, namely COX-1 and COX-2. The results suggested that the N,N-phthaloylacetamide structure, as a primary amide, has inhibitory activity against cyclooxygenase isoenzymes with a higher COX-1 selectivity. The conversion of the primary amide to secondary or tertiary derivatives lowered the potency but favored the COX-2 selectivity thus yielding the compounds with stronger COX-2 inhibiting activity.